Bayer Korea Divests OTC Oral Contraceptives To Gain Merck’s Market-Leading Brand
This article was originally published in The Tan Sheet
Executive Summary
In the first move by a South Korean pharma to acquire global brand drugs, Dong-A Pharm takes over four oral contraceptive products from Bayer Korea to beef up its OTC business and female product portfolios. Bayer Korea, meanwhile, turns its acquisition sights on MSD Korea’s market-leading Mercilon.